Synthesis and evaluation of haloperidol ester prodrugs metabolically activated by human carboxylesterase

[1]  Y. Choi,et al.  Microsuspension of fatty acid esters of entecavir for parenteral sustained delivery , 2018, International journal of pharmaceutics.

[2]  M. Hosokawa,et al.  Chemical synthesis of an indomethacin ester prodrug and its metabolic activation by human carboxylesterase 1. , 2018, Bioorganic & medicinal chemistry letters.

[3]  W. Cui,et al.  Electrospun fibrous membranes featuring sustained release of ibuprofen reduce adhesion and improve neurological function following lumbar laminectomy , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[4]  Benjamin J. Whalley,et al.  A novel PEG–haloperidol conjugate with a non-degradable linker shows the feasibility of using polymer–drug conjugates in a non-prodrug fashion , 2016 .

[5]  F. Drago,et al.  Antiangiogenic Effect of (±)-Haloperidol Metabolite II Valproate Ester [(±)-MRJF22] in Human Microvascular Retinal Endothelial Cells. , 2016, Journal of medicinal chemistry.

[6]  J. Leysen,et al.  Lipophilic nalmefene prodrugs to achieve a one-month sustained release. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[7]  M. Hosokawa,et al.  Synthesis and evaluation of atorvastatin esters as prodrugs metabolically activated by human carboxylesterases. , 2016, Bioorganic & medicinal chemistry letters.

[8]  A. Cataldi,et al.  Haloperidol metabolite II prodrug: asymmetric synthesis and biological evaluation on rat C6 glioma cells. , 2015, European journal of medicinal chemistry.

[9]  K. Brain,et al.  Skin permeation and ex vivo skin metabolism of O-acyl haloperidol ester prodrugs. , 2009, International journal of pharmaceutics.

[10]  K. Brain,et al.  Synthesis of haloperidol prodrugs and their hydrolysis by porcine liver esterase. , 2008, Drug metabolism letters.

[11]  Masakiyo Hosokawa,et al.  Structure and Catalytic Properties of Carboxylesterase Isozymes Involved in Metabolic Activation of Prodrugs , 2008, Molecules.

[12]  K. Chiba,et al.  Genomic Structure and Transcriptional Regulation of the Rat, Mouse, and Human Carboxylesterase Genes , 2007, Drug metabolism reviews.

[13]  F. Akhlaghi,et al.  Anti-Influenza Prodrug Oseltamivir Is Activated by Carboxylesterase Human Carboxylesterase 1, and the Activation Is Inhibited by Antiplatelet Agent Clopidogrel , 2006, Journal of Pharmacology and Experimental Therapeutics.

[14]  Teruko Imai,et al.  Substrate Specificity of Carboxylesterase Isozymes and Their Contribution to Hydrolase Activity in Human Liver and Small Intestine , 2006, Drug Metabolism and Disposition.

[15]  Tetsuo Satoh,et al.  Structure, function and regulation of carboxylesterases. , 2006, Chemico-biological interactions.

[16]  D. Murry,et al.  Methylphenidate Is Stereoselectively Hydrolyzed by Human Carboxylesterase CES1A1 , 2004, Journal of Pharmacology and Experimental Therapeutics.

[17]  P. Kuhn,et al.  Crystal structure of human carboxylesterase 1 complexed with the Alzheimer's drug tacrine: from binding promiscuity to selective inhibition. , 2003, Chemistry & biology.

[18]  W. Bosron,et al.  Binding and hydrolysis of meperidine by human liver carboxylesterase hCE-1. , 1999, The Journal of pharmacology and experimental therapeutics.

[19]  J. Cashman,et al.  Human liver carboxylesterase hCE-1: binding specificity for cocaine, heroin, and their metabolites and analogs. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[20]  K Hirano,et al.  Hydrolytic profile for ester- or amide-linkage by carboxylesterases pI 5.3 and 4.5 from human liver. , 1997, Biological & pharmaceutical bulletin.

[21]  W. Bosron,et al.  Metabolism of cocaine and heroin is catalyzed by the same human liver carboxylesterases. , 1996, The Journal of pharmacology and experimental therapeutics.

[22]  T. Satoh,et al.  Interindividual variation in carboxylesterase levels in human liver microsomes. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[23]  T. Satoh,et al.  Metabolic activation of CPT-11, 7-ethyl-10-[4-(1-piperidino)-1- piperidino]carbonyloxycamptothecin, a novel antitumor agent, by carboxylesterase. , 1994, Biological & pharmaceutical bulletin.

[24]  M. Jann,et al.  Pharmacokinetics of Haloperidol , 1989, Clinical pharmacokinetics.

[25]  K. Nambu,et al.  Enzymatic hydrolysis of haloperidol decanoate and its inhibition by proteins. , 1987, Biochemical pharmacology.

[26]  T. Fukami,et al.  The emerging role of human esterases. , 2012, Drug metabolism and pharmacokinetics.

[27]  R. Beresford,et al.  Haloperidol Decanoate , 2012, Drugs.

[28]  M Hosokawa,et al.  The mammalian carboxylesterases: from molecules to functions. , 1998, Annual review of pharmacology and toxicology.